BETHLEHEM, Pa., Oct. 11, 2017 -- B. Braun Medical Inc. will present its chronic care products at the Symposium on Advanced Wound Care Fall 2017 (SAWC) in Las Vegas, Nevada, from October 20 to 22. Attendees can visit booth #208 to learn about the Prontosan® line of wound healing products and the Flexima® 3S line of ostomy products, including:
- Prontosan Gel-X, the wound gel with betaine and polyhexanide to resist microbial colonization within a dressing and offer a gentle healing experience1
- Flexima 3S 2-Piece System ostomy product, with a guiding system designed for security
- Roll’Up Drainable Ostomy Pouches, with an integrated soft roll-up outlet
- B. Braun High Output System, including the High Output Pouch and Flow Collector with a 2-liter collection bag and kink-resistant, cuttable 5-foot-long white tubing
- Urostomy Pouches, featuring an open/closed tap with tactile open/close tap outlet
“With B. Braun Melsungen’s more than 40 years of experience with ostomy products and an extensive line of wound care products, B. Braun Medical will continue to extend its unique product solutions to patients and clinicians in the North American market,” said Jeff Straton, Vice President of New Business Development for B. Braun.
At SAWC, B. Braun will preview its myostoSM program for those living with an ostomy. For patients pre-surgery to many years post-ostomy, the soon-to-be-launched myosto program will include an online website resource and toll-free contact numbers that will offer general information about living with a stoma and measure patient satisfaction with B. Braun ostomy products.
For more information, visit www.BBraunUSA.com.
About B. Braun
B. Braun Medical Inc., a leader in infusion therapy and pain management, develops, manufactures, and markets innovative medical products and services to the healthcare industry. The company is committed to eliminating preventable treatment errors and enhancing patient, clinician and environmental safety. B. Braun Medical is headquartered in Bethlehem, Pa., and is part of the B. Braun Group of Companies in the U.S., which includes B. Braun Interventional Systems, Aesculap® and CAPS®.
Globally, the B. Braun Group of Companies employs more than 58,000 employees in 64 countries. Guided by its Sharing Expertise® philosophy, B. Braun continuously exchanges knowledge with customers, partners and clinicians to address the critical issues of improving care and lowering costs. To learn more about B. Braun Medical, visit www.BBraunUSA.com.
1 Bradbury s., Fletcher J. Prontosan Made Easy. Wounds Int. 2011.2(2), 1-6.
Contact:
Jason Ford
B. Braun Medical Inc.
610.997.4722
[email protected]


Australia’s Modern Gold Rush: Hobby Prospectors Flock to Victoria’s Golden Triangle
Boeing Secures Multi-Billion Dollar Defense Contracts for F-15IA Jets and E-4B Aircraft Support
Lloyds Banking Group to Close Invoice Factoring Business by End of 2025
Disney Agrees to $10 Million Settlement Over Child Privacy Violations on YouTube
Boeing Secures $8.6 Billion Pentagon Contract for F-15 Jets for Israel
China’s Iron Ore Buyer Pressures Mining Giants as New Supply Shifts Market Power
Citigroup to Exit Russia With Sale of AO Citibank to Renaissance Capital
Nike Stock Rises After CEO Elliott Hill Buys $1 Million in Shares
SoftBank Completes $41 Billion OpenAI Investment in Historic AI Funding Round
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies
ByteDance Plans Massive AI Chip Spending Boost as Nvidia Demand Grows in China
Vietnam’s EV Taxi Giant GSM Eyes Hong Kong IPO With $2–3 Billion Valuation
China’s LandSpace Takes Aim at SpaceX With Reusable Rocket Ambitions
BP’s Castrol Stake Sale Raises Debt Relief Hopes but Sparks Cash Flow Concerns
Star Entertainment Leadership Shake-Up Deepens as CFO and COO Exit Amid Ongoing Restructuring
Trump Administration Probes Corporate DEI Programs, Raising Questions for Google Stock
Anghami Stock Soars After Strong H1 2025 Results, Revenue Nearly Doubles on OSN+ Integration 



